Literatur
- 1
Briggs G G, Freeman R K, Yaffe S J.
Classification of drugs for teratogenic risk: an anachronistic way of counseling:
a reply to Merlob and Stahl.
Birth Defects Res Part A Clin Mol Teratol.
2003;
67
207-208
- 2
Centers for Disease Control .
Acquired rifamycin resistance in persons with advanced HIV disease being treated for
active tuberculosis with intermittent rifamycin-based regimens.
MMWR Morb Mortal Wkly Rep.
2002;
51
214-215
- 3
Centers for Disease Control .
Treatment of tuberculosis.
MMWR Recomm Rep.
2003;
52
1-77
- 4 Crofton J, Chaulet P, Maher D. Guidelines for the management of drug-resistant tuberculosis. World
Health Organization: Geneva 1997
- 5
Davidson P T.
Managing tuberculosis during pregnancy.
Lancet.
1995;
346
199-200
- 6
Deutsche .
Infektionsverhütung bei Tuberkulose in Gesundheits- und Sozialeinrichtungen.
Hyg Med.
1997;
22
523-534
- 7
Ellard G A.
Chemotherapy of tuberculosis for patients with renal impairment.
Nephron.
1993;
64
169-181
- 8
Espinal M a, Kim S J, Suarez P G. et al .
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes
in 6 countries.
Jama.
2000;
283
2537-2545
- 9
Gelband H.
Regimens of less than six months for treating tuberculosis.
Cochrane Database Syst Rev.
2000;
CD001362
- 10
Gosling R D, Uiso L O, Sam N E. et al .
The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.
Am J Respir Crit Care Med.
2003;
168
1342-1345
- 11
Gubler C, Ehmann T, Meyenberger C.
Nicht heilendes Magenulkus.
Dtsch Med Wochenschr.
2003;
128
1592-1594
- 12
Guttler A, Hammerschmidt S, Wirtz H. et al .
Unerwartete Ursache einer Fußwurzeldestruktion bei einem Diabetiker.
Dtsch Med Wochenschr.
2004;
129
1243-45
- 13
Iseman M D.
Treatment of multidrug-resistant tuberculosis.
N Engl J Med.
1993;
329
784-791
- 14
Jana N, Vasishta K, Saha S C, Ghosh K.
Obstetrical outcomes among women with extrapulmonary tuberculosis.
N Engl J Med.
1999;
341
645-649
- 15
Lessnau K, Qarah S.
Multidrug-resistant tuberculosis in pregnancy: case report and review of the literature.
Chest.
2003;
123
953-956
- 16
Narita M, Ashkin D, Hollender E S, Pitchenik A E.
Paradoxical worsening of tuberculosis following antiretroviral therapy in patients
with AIDS.
Am J Respir Crit Care Med.
1998;
158
157-161
- 17
Pletz M W, De Roux A, Roth A, Neumann K H, Mauch H, Lode H.
Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis:
a prospective, randomized study.
Antimicrob Agents Chemother.
2004;
48
780-782
- 18 Robert Koch-Insitut .Infektionepidemiologisches Jahrbuch für 2003. Berlin 2004
- 19
Schaberg T, Forssbohm M, Hauer B. et al .
Guidelines for drug treatment of tuberculosis in adults and childhood.
Pneumologie.
2001;
55
494-511
- 20
Schmid K, Schoerner C, Drexler H.
Beruflich erworbene Tuberkulosebehandlung bei einer Verwaltungsangestellten. Gutachterliche
Aspekte.
Dtsch Med Wochenschr.
2003;
128
432-434
- 21
Snider D E, Layde P M, Johnson M W, Lyle M A.
Treatment of tuberculosis during pregnancy.
Am Rev Respir Dis.
1980;
122
65-79
- 22
Thwaites G E, Nguyen D B, Nguyen H D. et al .
Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.
N Engl J Med.
2004;
351
1741-51
- 23
Tortoli E, Dionisio D, Fabbri C.
Evaluation of moxifloxacin activity in vitro against Mycobacterium tuberculosis, including
resistant and multidrug-resistant strains.
J Chemother.
2004;
16
334-336
- 24
Volmink J, Garner P.
Directly observed therapy for treating tuberculosis.
Cochrane Database Syst Rev.
2003;
1
CD003343
- 25 WHO .Anti-tuberculosis drug resistance in the world. WHO Global Tuberculosis Programme:
Genf 1994 - 1997
- 26 WHO .Fact Sheet N°104. Tuberculosis. WHO 2004
Dr. med. Frank Grünhage
Medizinische Klinik und Poliklinik I
Sigmund-Freud Straße 25
53105 Bonn
Phone: 0049/228/2875509
Fax: 0049/228/2874322
Email: frank.gruenhage@ukb.uni-bonn.de
